- 전체
- Kidney cancer
- Lung Cancer
GenoPlex™ MAP (Model: RCC 3-Plex)
- Description: Kidney cancer detection kit Multiplex Human Renal Cell carcinoma biomarker Test kit
- - Features: Luminex MAP technology, bead-based 3-plex assay In vitro kidney cancer diagnostics
- - Reactivity: Human
- - Sample type: Serum, Plasma
- - Sensitivity: >21 pg/ml
- - Size: 96 tests/kit
- - Storage: 2-8℃
roduct Information
GENOMINE offers the GenoPlex™ MAP Human Renal Cell Carcinoma detection kit. The Cancer Biomarker Panel includes three-plex assay, which simultaneously measures three serum biomarkers, N-nicotinamide metyltransferase(NNMT), Non-metastatic cells 1(NM23A) and L-plastin(LCP1).
The combination of the three serum biomarkers that discriminate between disease-free and Renal Cell Carcinoma patients was characterized and validated by GENOMINE and Yonsei University Medical School.
Using a scoring algorithm, the profile of three biomarkers in circulation was used to detect all stages of Renal Cell Carcinoma patients with high sensitivity and accuracy. The assays can be used to quantify these biomarkers in serum, plasma, and cell/tissue culture supernatant samples.
Specifications
- Detecting of 3 kidney cancer markers in a single well
- Highly sensitive
- Multiplexing reduces costs and time
- Generates more data with less sample
Advantages and Benefits
Detection Method | Luminex xMAP |
---|---|
Specificity | NNMT, LCP1, NM23A |
Reactivity | Human |
Sample type | Plasma, Serum |
Array Type | Antibody arrays |
Cross reactivity | Non detectable or negligible within the panel |
Sensitivity |
|
Detection range |
|
Accuracy |
|
Precision |
|
Storage |
|
Order Details
Product Name | Cat. No. | Size | Price |
---|---|---|---|
GenoPlex™ MAP RCC-3Plex | DL101 |
1 kit | Inquire |
Order Inquiry: gjkim@genomine.com